The 12 Year Gap: Why Women Live Longer but Suffer More

At a recent gathering in Singapore, Health Minister Ong Ye Kung shared a statistic that silenced the room. Women in the region live roughly four and a half years longer than men. On the surface, this looks like a triumph. The reality is far more grim. Half of that extended lifespan is consumed by poor health. It is a hidden crisis tucked inside what appears to be a public victory.

We often treat longevity as a simple metric of heartbeats. Ong is arguing for a harder standard to measure. He refers to it as the morbidity gap. This is the distance between how long a person lives and how well they live that time. For men in Singapore, this gap sits just under ten years. For women, it stretches out to twelve. That extra time is not a gift. It is a heavy load of chronic disease that current medical systems struggle to manage.

The Biology Behind the Burden

Ong was speaking at the 13th Milken Institute Asia Summit, a three day event that drew about 1,500 leaders from 50 countries. He was in conversation with Dr. Jill Biden, who chairs the Milken Institute Women's Health Network. The setting was formal. The message was direct. Modern healthcare is pivoting. We are moving away from battling infectious diseases and toward managing chronic conditions that build up over decades.

This shift is not a fleeting trend. It is a biological reality. As people age, the body faces new vulnerabilities. Ong noted that women face more biological hurdles during this phase. They are not just living longer. They are navigating a different kind of aging. This demands a different kind of medicine. One that looks at the whole person, not just the acute symptom.

The implication is serious. If we do not address this gap, we are merely extending the period of suffering. We are adding years to life, not life to years. This is a distinction that matters. It changes how we define success in health. It is not about the last breath. It is about the quality of the last decade.

Singapore's Fiscal Advantage

Ong highlighted a unique position Singapore holds in this global puzzle. The country spends about 4.5 percent of its GDP on healthcare. This gives them what he called fiscal headroom. It is a rare luxury. Many nations are stuck. They cannot afford to shift resources from acute care to prevention. Their systems are already strained.

But Singapore has the capacity to invest in the future. Ong said they have the opportunity to be an urban environment that models this new approach. They can divide resources between treating the sick and keeping the healthy well. This is not just a policy choice. It is a strategic one. It is a bet that prevention is more sustainable than cure.

This model could become a blueprint for other wealthy nations. If a city state can manage this transition, larger economies might follow. The key is having the financial stability to make long term investments. It is not just about spending more. It is about spending smarter. It is about changing the entire structure of how we think about health.

A Global Call for Sex Specific Research

The conversation went beyond Singapore's borders. Ong and Biden discussed the need for more sex specific health research. This is a gap in current medical science. Most drugs and treatments are tested on a general population. But men and women experience diseases differently. Their bodies respond to treatments in distinct ways.

Biden, with her background in public health advocacy, brought a personal touch to the discussion. She emphasized the importance of listening to women's experiences. This is not just a scientific issue. It is a social one. It is about recognizing that women's health has been historically underfunded and understudied.

The Milken Institute is positioning itself as a leader in this space. By hosting this dialogue, they are signaling a shift in global health priorities. The focus is moving from generic care to personalized, sex specific interventions. This is where the future of medicine lies. It is a more precise, more effective approach. It is a necessary evolution.

The Road Ahead for Healthy Longevity

The challenge is clear. We need to close the morbidity gap. This requires a fundamental shift in how we design our healthcare systems. It means investing in prevention. It means understanding the biological differences between men and women. It means accepting that living longer is not enough.

Ong's vision is not just for Singapore. It is a model for the world. If we can create urban environments that support healthy longevity, we can change the trajectory of global health. It is a high bar. But it is the right one. The goal is not just to survive. It is to thrive. And that starts with acknowledging the gap and working to close it.